Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIOVAN 80MG TABLETS | 80MG | TABLET | Resolved | 2019-12-16 | 2020-03-27 | 101436 |
| DIOVAN 160MG TABLETS | 160MG | TABLET | Resolved | 2020-01-13 | 2020-03-20 | 103181 |
| DIOVAN | 40MG | TABLET | Resolved | 2020-03-09 | 2020-04-17 | 108259 |
| DIOVAN | 40MG | TABLET | Resolved | 2020-04-22 | 2020-05-21 | 112812 |
| DIOVAN | 320MG | TABLET | Resolved | 2020-04-22 | 2020-05-05 | 112809 |
| DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Resolved | 2023-04-28 | 2023-10-04 | 191074 |
| DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Actual shortage | 2024-03-21 | 2024-04-30 | 222962 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2018-09-28 | 2018-10-17 | 62545 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2022-09-14 | 2022-10-07 | 169228 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-02-11 | 2019-04-29 | 75343 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-06-05 | 2019-08-02 | 85629 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-04-27 | 2018-06-06 | 47338 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-11-23 | 2019-01-03 | 67490 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-02-21 | 2020-04-21 | 106958 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-03-31 | 2020-04-21 | 110235 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-04-27 | 2020-05-21 | 113330 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-05-21 | 2020-08-28 | 115462 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
| ARZERRA | 100MG | SOLUTION | Resolved | 2017-03-23 | 2018-10-17 | 4096 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| VOLTAREN | 100MG | SUPPOSITORY | Discontinued | 2017-05-01 | 2017-11-02 | 8504 |
| VOLTAREN SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-04-02 | 2019-09-11 | 80298 |
| VOLTAREN SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-07-10 | 2019-09-06 | 89039 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| VOLTAREN | 50MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-01-08 | 2020-03-10 | 102699 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| TEGRETOL CHEWTABS 200 MG | 200MG | TABLET | Discontinued | 2017-05-01 | 2017-06-06 | 8500 |
| TEGRETOL CHEWTABS 100 MG | 100MG | TABLET (CHEWABLE) | Discontinued | 2017-09-27 | 2017-09-27 | 23765 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SEBIVO | 600MG | TABLET | Discontinued | 2019-07-10 | 2019-11-06 | 89042 |
| SANDOSTATIN | 200MCG | SOLUTION | Discontinued | 2022-02-08 | 2022-03-07 | 154429 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |
| RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-02-08 | 2022-04-05 | 154439 |